Olaf Merkel

Associate Prof. Dr.

Medical University of Vienna

Austria

Research Interests

Explore related searches

Professors in Austria Professors in Immunology Immunology professors in Austria

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Year:

2020

Collaborators (13)

Martin Janz

Max Delbrück Centrum für Molekulare Medizin Berlin Buch

GERMANY

View details

Marek Mraz

University Hospital Brno

CZECH REPUBLIC

View details

Heidi Neubauer

Assistant Professor, Group Leader

University of Veterinary Medicine Vienna

AUSTRIA

View details

Mark Zimmerman

Dana-Farber Cancer Institute

UNITED STATES

View details

Luca Mologni

University of Milano-Bicocca

ITALY

View details

Harald Esterbauer

Head Molecular Diagnostics

Medical University of Vienna

AUSTRIA

View details

Katsuhiro Miura

Associate Professor

Nihon University School of Medicine

JAPAN

View details

Berend Snijder

Assistant Professor

ETH Zürich

SWITZERLAND

View details

Marius Mayerhoefer

Professor

Weill Cornell Medicine

UNITED STATES

View details

Florian Grebien

Professor

University of Veterinary Medicine Vienna

AUSTRIA

View details

Veronika Sexl

Professor, Head of Institute

Vetmeduni

AUSTRIA

View details

Bernhard Gillissen

Charité - Universitätsmedizin Berlin

GERMANY

View details

Theresa Balber

Medical University of Vienna

AUSTRIA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Olaf Merkel

Research Interests

Explore related searches

Contact this professor

Articles (9)

Aberrant Expression of and Cell Death Induction by Engagement of the MHC-II Chaperone CD74 in Anaplastic Large Cell Lymphoma (ALCL).

Super-enhancer-based identification of a BATF3/IL-2R-module reveals vulnerabilities in anaplastic large cell lymphoma.

Functional Precision Medicine Provides Clinical Benefit in Advanced Aggressive Hematologic Cancers and Identifies Exceptional Responders.

Whole Exome Sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential therapeutic target.

Correction: Dependency on the TYK2/STAT1/MCL1 axis in anaplastic large cell lymphoma.

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

STAT3 and TP53 mutations associate with poor prognosis in anaplastic large cell lymphoma

IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma.

Thyroid and androgen receptor signaling are antagonized by μ-Crystallin in prostate cancer.

Collaborators (13)

Martin Janz

Marek Mraz

Heidi Neubauer

Mark Zimmerman

Luca Mologni

Harald Esterbauer

Katsuhiro Miura

Berend Snijder

Marius Mayerhoefer

Florian Grebien

Veronika Sexl

Bernhard Gillissen

Theresa Balber

Make your next move.